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N-methylformamide induces changes on adhesive
properties and lung-colonizing potential of Ml 4
melanoma cells
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Summary We have studied whether N-methylformamide can affect the expression pattern of adhesion molecules and the attachment
behaviour of M14 human melanoma cells. The role of N-methylformamide on experimental and spontaneous pulmonary metastases from
M14 cells in nude mice was also investigated. We demonstrate that N-methylformamide in vitro pretreatment of M14 cells, although inducing
a significant increase in the expression of a2,1l, a611 and avj3 integrin receptors, slightly modifies a5p1 heterodimer and P1 subunit
expression. After this modulation, enhancement of cell adhesion to laminin, collagen 1, vitronectin and fibrinogen, which is blocked by specific
anti-integrin antibodies, also occurs. No changes in binding to fibronectin are observed. In vitro N-methylformamide pretreatment also results
in an increased number of experimental nodules and in a decrease in spontaneous metastases. Moreover, in vivo treatment with N-
methylformamide significantly reduces the number of spontaneous metastases. Collectively, these data show that N-methylformamide
modulates the expression of some adhesion receptors, cell adhesion to laminin, collagen 1, vitronectin and fibrinogen as well as the metastatic
behaviour of M14 cells. Our data also suggest that the effect of N-methylformamide might be evaluated in combination with antineoplastic
agents for the treatment of human melanoma.
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Understanding of the process of metastasis is essential in the
management ofcancer as most deaths occur because ofmetastatic
disease. Crucial steps in the process of metastasis are the release
and migration oftumour cells from the primary site, penetration of
the blood vessel wall, arrest in the microcirculation of distant
organs and subsequent extravasation (Liottaand Stetler-Stevenson,
1991). The adhesion, invasion and metastatization of tumour cell
can be controlled by extracellular matrix (ECM) components that
form tissue barriers and act as adhesive substrates (Ruoslahti,
1992). Furthermore, the ECM transmits signals to the cells
through the receptors that mediate adhesion, growth factors and
matrix bound cytokines (Ruoslahti, 1992).
A number of recent observations indicate that cell adhesion
molecules (CAMs), by virtue of their ability to mediate the inter-
action of tumour cells with extracellular matrix components and
with other cells, also play a crucial role in the multistep process of
metastasis formation (Hynes and Lander, 1992). At least four cate-
gories of CAMs are currently recognized, including integrins
(Hemler, 1990), a subset ofmolecules ofthe immunoglobin super-
gene family (Williams, 1987), a number of the LEC-CAM family
(Stoolman, 1989) and cell surface proteoglycans (Ruoslahti,
1989). It has been demonstrated that qualitative as well as quanti-
tative changes in CAMs expression (including their decrease,
enhancement and appearance) occur during tumour progression of
malignant human tumours, including melanoma (Hart et al, 1991;
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Mortarini and Anichini, 1993; Timar et al, 1996). In particular, the
,1 and P3 subfamilies ofintegrins are involved in tumour progres-
sion and metastasis (Felding-Habermann et al, 1992; Seftor et al,
1992; Danen et al, 1993; Natali et al, 1993; Schadendorf et al,
1993). Therefore, CAMs might represent an ideal target for new
agents that are able to alter their expression and to inhibit specific
steps in the metastatic process (Reich et al, 1988; Wang and
Steams, 1988).
Among these putative candidates, N-methylformamide (NMF)
is a differentiating compound that has been shown to affect metas-
tasis in several murine tumour cells, including lung carcinoma
(Greco etal, 1990), hepatocarcinoma (Tofilon et al, 1987; Iwakawa
et al, 1987), neuroblastoma (Iwakawa et al, 1994) and mammary
carcinoma (Iwakawa et al, 1987; Iwakawa et al, 1989). Depending
on the experimental setting, NMF may exert both enhancing and
inhibiting effects on tumour metastases. In particular, the enhance-
ment of metastases is observed when murine tumour cells are
treated with NMF before intravenous inoculation (Tofilon et al,
1987; Takenaga, 1984), whereas there is a reduction when the
agent is given after tumour cell inoculation (Iwakawa et al, 1987;
Tofilon et al, 1987; Greco et al, 1990; Iwakawa et al, 1994).
As the tendency of tumour cells to leave the primary tumour
mass implies at least temporary changing of the original intercel-
lular interaction, the purpose ofthis study was to evaluate whether
NMF is able to alter the expression of some adhesion molecules
and the metastatic ability of a human tumour cell line. To address
this issue we chose a well characterized experimental model avail-
able in ourlaboratory that uses the melanoma M14 cell line (Greco
andZupi, 1987). Inparticular, we analysed whether (a) NMF treat-
ment modulates the expression of some integrins and the attach-
ment behaviour of M14 line; (b) in vitro NMF pretreatment of
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M14 cells affects spontaneous and experimental metastases; and
(c) in vivo NMF treatment of nude mice bearing M14 tumours
interferes with the metastatic capacity.
MATERIALS AND METHODS
Cell culture and N-methylformamide treatment
The human malignant melanoma cell line M14 (Greco and Zupi,
1987) was maintained as monolayer cultures in RPMI-1640
supplemented medium at 37°C in a 5% carbon dioxide humidified
atmosphere. Exponentially growing cells were treated in vitro for
24 h with 170 mM (1%) NMF (Sigma, Milan, Italy) and differen-
tially processed according to the in vitro and in vivo experiments
to be performed. Pure solution of NMF was diluted in supple-
mented medium to the final concentration.
Antibodies
The following antibodies to different integrins were used: clone
P1E6 (anti-a2 chain, Becton Dickinson, San Jose, CA, USA),
clone P1D6 (anti-aS chain, Oncogene Science, Manhasset, NY,
USA), clone GoH3 (anti-a6 chain, Immunotech S.A., Marseille,
France), clone VNRI47 (anti-av chain, Telios, San Diego, CA,
USA), clone CA3 (anti-aIIb chain, Chemicon Intemational,
Temecula, CA, USA), clone 4B4 (anti-Pl chain, Coulter Hialeah,
FL, USA), clone mAbl3 (anti-P[ chain, Becton Dickinson), clone
RUU-PL7F12 (anti-53 chain, Becton Dickinson), clone AA3
(anti-f4 chain, Becton Dickinson), clone P1F6 (anti-av,5
complex, Chemicon International).
Flow cytometric analysis
The expression of a2, aS, a6, av, alIb, PI, P3, P4 subunits was
determined by indirect immunofluorescence by means of flow
cytometric analysis (FACScan, Becton Dickinson) after 24 h of
170 mm NMF exposure. A total of 1 x 106 cells per sample were
incubated with complete medium or saturating concentrations of
primary antibody for 1 h at 4°C. Cells were then incubated for 1 h
at 40C with 50g1 ofFITC-goat anti-mouse or FITC-sheep anti-rat
(Cappel, West Chester, CA, USA). To exclude non viable-cells,
5 p1 ofapropidium iodide solution (1 mg ml-l) were added to each
sample before cytofluorimetric analysis. At least 10 000 cells per
sample (in triplicate) were analysed. The histograms were
analysed using a Becton Dickinson software package.
Cell adhesion and inhibition assay
Flat-bottom 96-well plates (Costar, Cambridge, MA, USA) were
precoated with one of the following compounds dissolved in
phosphate-buffered saline (PBS): collagen I (Coll I, 10jg ml',
Sigma), laminin (LN, 2 ig ml', Gibco, UK), fibronectin
(FN, 5 ,ug ml-', Sigma), vitronectin (VN, 1 ,ug ml-', Telios), and
fibrinogen (FB, 5 ,ug ml-', Sigma). The compounds were left to
absorb in the wells overnight at 40C. The plates were rinsed three
times with PBS and then incubated at room temperature for 1 h
with 200g1 of PBS containing 1% BSA (Sigma) to prevent non-
specific cell adhesion. Control cells or cells treated 24 h with
170 mm NMF were labelled by incubation with chromium-S1-
labelled sodium chromate (50gCi per 106 cells) for 1 h at 37°C.
After two washings with RPMI medium containing 1% bovine
serum albumin (BSA) 5 x 104 of the labelled cells were added
to each well in 100 jl of serum-free medium. After 30, 60
and 120 min incubation at 37°C, wells were washed with
PBS to remove non-adherent cells, and attached cells were lysed
with 2% sodium dodecyl sulphate (SDS) for 10 min. The radio-
activity was counted using a gamma counter (LKB 1261 Multi-
gamma) and the percentage of cell adhesion was calculated as
follows:
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Figure 1 FACScan analysis of the a2 (P1E6), a6 (GoH3), a5 (P1D6), av (VNR147), ,Bl (mAbl3), P4 (AA3), P3 (RUU-PL7F12) and allb (CA3) integrin subunits
in NMF-treated (dotted area) or -untreated (white area). The solid line indicates the negative control. The histograms are representative of three different
experiments with similar results
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% cell adhesion = c.p.m. adherent cells
c.p.m. adherent cells +
c.p.m. non-adherent cells
x 100
In experiments in which anti-human integrin antibodies were
tested, labelled cells were incubated in the presence of either the
control culture medium or the dilution of antibodies for 1 h at 4°C.
Then, the cells were plated and the number of adherent cells was
determined after 1 h adhesion as above. As a negative control,
adhesion to 1% BSA was determined. All the experiments were
carried out in quadruplicate.
Evaluation of metastatic ability in athymic mice
Six- to eight-week-old male CD- I nude (nu/nu) mice, purchased
from Charles River Laboratory (Calco, Italy) were used. Mice
were housed under pathogen-free conditions and received acidified
and sterilized water and y-irradiated commercial food ad libitum.
Manipulations were carried out under sterile conditions in a
laminar air flow hood. Each experimental group of mice included
10-20 animals.
The effect of in vitro pretreatment with NMF (170 mm for 24 h)
on M 14 experimental and spontaneous metastases was evaluated
by injecting mice with 1 x 106 viable cells via the tail vein (intra-
venous, i.v) or by injecting 1 x 107 viable cells into the muscle of
the hind leg (intramuscular, i.m.). For spontaneous metastases
experiments, we have chosen the i.m. injection because this kind
of implantation resulted in more homogeneous tumour growth
than that obtained using a subcutaneous implant and obtained
100% take after tumour cell injection. Spontaneous lung metas-
tases were observed in all mice given i.m. tumour cell injections.
The effect of in vivo NMF treatment on spontaneous metastases
was assessed by implanting mice i.m. with I x 107 viable cells.
Twenty-four hours later, NMF at 200 mg kg' day was injected
Laminin
intraperitoneally (i.p.) for 12 consecutive days. The number ofexper-
imental and spontaneous metastases were evaluated on days 28 and
35 after tumour implant respectively. The mice were killed and the
lungs were excised and fixed in Bouin's solution and the median
number of metastatic nodules counted with the aid of a dissecting
microscope. The mice were also examined daily and tumour growth
was monitored, as reported previously (Greco et al, 1990).
The results were analysed by the Mann-Whitney U-test for
statistical significance. Differences were considered significant at
P-values < 0.05 (two-sided).
All procedures involving animals and their care were in accord
with the institutional guidelines in compliance with national and
international laws and policies [ECC Council Directive 86/609,
OJL 358, 1 December 1987, and the National Institutes of Health
(NIH) Guide for the Care and Use of Laboratory Animals, NHI
publication no. 85-23, 1985].
RESULTS
Effect of N-methylformamide on integrin expression
To determine whether NMF affects the expression of some
integrins involved in metastasis, M14 cells were treated in vitro
with 170 mm NMF for 24 h and at the end of treatment the cells
were analysed by flow cytometry.
As shown in Figure 1, untreated M 14 cell line expresses oc2, (x5,
otv, P1 and (3 subunits at a high level, u6 at an intermediate level,
but does not express (4 and otllb integrin subunits. NMF treatment
induces a significant enhancement of (2, u6, and (3 integrin
subunits expression. The modal fluorescence intensity value
increases from 15.39 to 46.97 for u2, from 5.23 to 10.36 for o6
and from 18.43 to 45.35 for (3. In contrast, levels of o5 and (1
subunits on the cell surface were only slightly modified after NMF
treatment. Modal fluorescence intensity values of the distribution
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Figure 2 Time dependent analysis of cell adhesion (30, 60 and 120 min) of NMF-treated (-) and -untreated (Lii) M14 cells. Laminin (2 !tg ml-'), collagen
(10 pg ml-'), vitronectin (1 pg ml-'), fibrinogen (5 pg ml-') and fibronectin (5 pg ml-1) were used as substrates. Control adhesion to BSA was less then 5%. Data
shown are from triplicate determinations. sd of triplicate determinations did not exceed 15%
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Figure 3 Inhibition of adhesion of NMF-treated (-) and -untreated (E) M14
cells to laminin (2 gg ml-1), collagen I (10 gg ml-1), vitronectin (1 jg ml-'), and
fibrinogen (5 gg ml-1). A 60-min adhesion assay was used to test the function
blocking effects of the following antibodies: anti-51 (4B4, ascites, 1:20
dilution), anti-a6 (GoH3, 10 jg ml-'), anti-a2 (P1 E6, ascites, 1:500 dilution),
anti-53 (RUU-PL7F12, 2 jg ml-1), and anti-,B5 (P1F6, ascites, 1:500 dilution).
Control adhesion to BSA was less then 5%. Data shown are from triplicate
determinations. s.d. of triplicate determinations did not exceed 15%
ofuntreated and NMF-treated cells moves from 25.00 to 35.00 for
aS, and from 60.28 to 71.98 for P1 respectively. The exposure of
M14 cells to NMF does not modify av expression and does not
induce the expression of ,34 and alIb subunits.
Effect of N-methylformamide on cell adhesion to
laminin, collagen 1, fibronectin, vitronectin and
fibrinogen
A time-dependent analysis ofcell adhesion ranging from 30 to 120
min was performed to establish whether differences in cell-surface
expression between NMF-treated and -untreated cells could reflect
differences in the level of attachment to LN, Coll I, FN, VN and
FB. As shown in Figure 2, adhesion of untreated M14 cells to FN
was greater than that to LN, Coll I, VN and FB for all the observed
times. After a 60-min adhesion assay, approximately 70% of cells
adhere to FN whereas approximately 10-25% of them adhere to
LN, Coll I, VN and FB. Treatment with 170 mM NMF for 24 h
induces an increase in cell attachment to LN, Coll I, VN and FB,
ranging from 45% to 75%. In all cases except for VN, this increase
is evident at all times, starting from 30-min adhesion time. In
contrast, the effect of NMF on the adhesion to VN is only clearly
evident at adhesion times less than 120 min; the percentage of
increase in cell adhesion is about 80% and 55% after 30 and
60 min, respectively, and only 10% after 120 min.
No differences in cell adhesion to FN were observed between
NMF-treated and -untreated cells, even at the shortest time period.
Effect of anti-integrin antibodies on cell adhesion
To evaluate the specific role of some integrins in mediating the
adhesive properties of M14 cells to Coll I, LN, VN and FB, an
antibody inhibition assay was performed (Figure 3). The mono-
clonal antibody directed against the P1 subunit reduced the adhe-
sion ofuntreated M14 cells to LN andColl Ibut not to VN and FB.
The monoclonal anti-a6 antibody inhibited adhesion to LN but not
to Coll I. The monoclonal anti-a2 antibody inhibited adhesion to
Coll I. Anti-,3 antibodies inhibited adhesion to both VN and FB
but not to LN; whereasanti-avP5 antibodies inhibited adhesion to
VN. Similar inhibition was observed when NMF-treated cells
were preincubated with the same antibodies.
Anti-,3 and -a6 were used as controls for adhesion to LN and
Coll I respectively. Anti-,B1 was used as control for adhesion to
VN and FB.
Effect of N-methylformamide on M14 metastatic ability
To investigate whether a correlation exists between the capacity to
adhere to ECM compounds in vitro and the metastatic potential of
M14 cells, the effect of NMF on experimental and spontaneous
metastases was evaluated. The results that are reported in Table 1
summarize the effects of in vitro NMF treatment on the experi-
mental and spontaneous pulmonary metastases. The effect ofNMF
administration in M14 tumour-bearing mice on spontaneous
metastases was also reported. The median number ofexperimental
and spontaneous lung nodules was evaluated on days 28 and 35
afterthe injection ofcells respectively. It is evident that the in vitro
treatment with NMF produces a statistically significant increase in
the median number of experimental metastases compared with
untreated cells (18 vs 8, P = 0.01), whereas the median number of
spontaneous- metastases is significantly reduced (11 vs 16, P =
0.012). The in vivo NMF treatment of mice bearing M14 tumours
leads to a significant decrease in lung metastases compared with
control animals (6 vs 16, P = 0.0001).
The effect of NMF on primary tumour growth was also evalu-
ated. The data demonstrate that in vivo NMF treatment does not
significantly affect primary tumour growth. In fact, the tumour
weight in grams evaluated at the nadir of the NMF effect, is
1370 mg ± 258 and 1187 mg ± 302 for untreated and NMF-treated
mice respectively.
Table 1 In vitro and in vivo N-methylformamide effect on M14 experimental and spontaneous lung metastases
Treatment Median (interval) of metastases and statistical significance (P)
Experimentala Spontaneousb P
Control 8 (5-24) 16 (6-30)
NMF vitro (170 mm for 24 h) 18 (12-29) 0.01 11 (2-21) 0.012
NMF vivo (200 mg kg-' dar1 for 12 days) - 6 (0-18) 0.0001
al x 106 untreated (control) or NMF in vitro pretreated cells (NMF vitro) were injected i.v. in mice. Metastatic nodules were counted at day 28 after
tumour implant. bl X 107 untreated (control) or NMF in vitro pretreated (NMF vitro) cells were i.m. injected in mice. In the case of NMF vivo group
(NMF vivo), 1 x 107 untreated cells were i.m. injected in mice and i.p. treatment with NMF for 12 days was started 24 h after tumour implant.
Metastatic nodules were counted at day 35 after tumour implant. *Statistical significance was evaluated according to the Mann-Whitney U-test
(two-sided) comparing the median values of treated group vs control group.
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DISCUSSION
Our findings demonstrate that NMF can modulate the adhesion
molecule expression pattern and the attachment behaviour ofM14
melanoma cells. In particular, NMF induces an increase in the
cell-surface expression of LN (a6p1), Coll I (a2,1), VN and FB
(avP3) receptors, whereas only a slight modulation on PI integrin
subunit and FN(aSP) receptor is observed. No modulation on the
expression of allb, av and ,4 subunits is found. In contrast to
previous findings indicating the presence of aIIbP3 integrin on
several cancer cells (Chen et al, 1992; Timar et al, 1996) we found
no expression of this integrin in M14 cells. The fact that the M14
cells express the av but not the aIIb subunit indicates that the 03
integrin molecule is expressed on the surface of M14 cells in the
form ofa heterodimer av,B3.
The increase in the expression ofa2pl, a6,1 andavP3 recep-
tors leads to functional changes affecting the binding of the three
integrins for their ligands. Indeed, we demonstrate that NMF is
able to increase the adhesion of M14 cells to LN, Coll I, VN and
FB. We also show that long time periods of cell adhesion may
obscure differences in the initial matrix interaction process. In fact,
in the case ofVN the effect ofNMFon the adhesion is only clearly
evident at the adhesion times less than 120 min. It is possible that
long time periods allow metabolic activities, such as modifications
of the provided matrices and deposition of additional matrix
protein, which may affect the outcome ofthe adhesion assay. Our
data also show that the adhesion of untreated and NMF-treated
cells to LN and Coll I is mediated by a601 integrin and a2p1
respectively; adhesion to VN is mediated by both avP3 and avP5
receptors, whereas adhesion to FB is mediated by avP3 integrin.
We also demonstrate that the relatively small increase in a5OP
expression is not sufficient to have an impact on FN binding, even
when using short time periods of adhesion assay. The observation
that NMF does not modulate adhesion to FN confirms the results
of a number of previous studies in which no positive correlation
was observed between the capability ofcells to adhere to FN and
their tumorigenic and/or metastatic behaviour (Terranova et al,
1984; Dedhar and Saulnier, 1990).
To assess whether the modulation of the cell adhesion pattern
by treatment with NMF can modify the metastatic potential, we
determined the NMF effect on experimental and spontaneous
pulmonary metastasis ofnude mice injected with M14 cells.
We have shown that in vitro NMF pretreatment of M14 cells
exerts an enhancing effect on experimental tumour metastasis. In
vitro adhesion data provide a possible explanation regarding the
metastatic cell behaviour after NMF pretreatment. It is possible
that the enhanced expression of some integrin receptors induced
by NMF alters the adhesion to blood vessels and mediates cell-cell
and cell-matrix interactions. In addition, in murine model systems
it has been reported that in vitro NMF pretreatment increases the
number ofexperimental lung colonies (Takenaga, 1984; Tofilon et
al, 1987). In addition, our findings add further evidence to that of
other authors, demonstrating a correlation between increased
expression of some integrin receptors and enhanced metastatic
capacity (Takenaga, 1984; Terranova et al, 1984; Chan et al, 1991;
Gehlsen et al, 1992; Mortarini and Anichini, 1993; Schadendorfet
al, 1993; Timar et al, 1996).
We also show that spontaneous metastases decrease both after
the injection of in vitro NMF pretreated cells and after the in vivo
treatment oftumour bearing mice with NMF for 12 days. However,
a significant difference in the number ofmetastases between NMF
in vitro treatment and NMF in vivo administration is observed
(6 vs 11, P = 0.015). The continuous treatment of animals with
NMF could also exert an effect on the host that may be responsible
for this difference. We suggest that NMF treatment might exert a
directeffect on the primary tumour, altering the expression ofsome
cell adhesion receptors. In the present model, NMF-induced upreg-
ulation ofsome adhesion molecules may facilitate both the tumour
cell adhesion at the site of growth and cell-cell interaction, thus
reducing the number of cells able to detach from the growing
primary tumour. Moreover, NMF may also inhibit spontaneous
metastases affecting the host endothelial integrins, such as avP3.
In fact, avP3 adhesion receptor has been recently identified as a
markerofangiogenic blood vessels in chickens and man (Brooks et
al, 1994a) and antagonists of these integrins induces apoptosis of
the proliferative angiogenic vascular cells (Brooks et al, 1994b).
The effect of NMF on spontaneous metastases has also been
demonstrated previously in different model systems, and several
mechanisms have been postulated for the antimetastatic effect of
the agent (Iwakawa et al, 1987; Tofilon et al, 1987; Iwakawa et al,
1989; Greco et al, 1990; Iwakawa et al, 1994). It has been hypoth-
esized that NMF may induce tumourcells to form aless aggressive
differentiated phenotype, resulting in a decrease in metastatic
potential (Spremulli and Dexter, 1984). In a previous paper we
demonstrated that NMF produces a significant increase in splenic
NK cell activity in Lewis lung carcinoma-bearing mice and we
suggested that NMF could promote differentiation of NK
precursor cells in tumour-bearing hosts in which maturation
defects had been caused by the neoplastic disease (Greco et al,
1990). Alternatively, NMF could act as an immunomodulating
agent whose effect is specifically detectable in immunodepressed
hosts (Parhar and Lala, 1985). Finally, other authors have
suggested that NMF may act by exerting a stress-like reaction
upon the host (Nicolson and Custead, 1985).
In conclusion, the results ofthe present work suggest that NMF
might be used in combination with antineoplastic agents for the
treatment ofhuman melanoma.
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